Werner syndrome (WS) is an uncommon autosomal recessive disease characterized by premature aging and genetic instability, and associated with a high incidence of specific, uncommon cancers. The gene mutated in WS, WRN, belongs to the family of RecQ helicases and encodes both 3' -> 5' DNA helicase and 3"""""""" -> 5' DNA exonuclease activities. Biochemical studies indicate that the helicase preferentially unwinds DNA harboring alternative structures and that the exonuclease preferentially excises mismatched nucleotides at the 3'-terminus. Cloning and purification of WRN affords us the opportunity to study its biochemistry in detail and use these findings in concert with other projects in this program to understand how the wild-type WS protein, WRN, suppresses genetic instability and cancer. In order to gain insights into the in vivo fianctions of the WS protein, we will 1. identify and characterize proteins that interact physically and functionally with WRN, and 2. establish model in vitro systems to determine the involvement of WRN in cross-link repair. In addition, we will examine WRN single nucleotide polymorphJsms in the general population for functional effects, and analyze polymorphic variants and WRN mutations in cancers associated with WS, in particular, sarcomas. These studies will provide the biochemical foundation for the proposed program project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA077852-09
Application #
7369758
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
9
Fiscal Year
2007
Total Cost
$255,458
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Orozco, Javier I J; Knijnenburg, Theo A; Manughian-Peter, Ayla O et al. (2018) Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun 9:4627
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202
Lee, Su-In; Celik, Safiye; Logsdon, Benjamin A et al. (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42
Salk, Jesse J; Schmitt, Michael W; Loeb, Lawrence A (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269-285
Davis, Luther; Zhang, Yinbo; Maizels, Nancy (2018) Assaying Repair at DNA Nicks. Methods Enzymol 601:71-89
Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383
Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6
Poston, Jacqueline N; Becker, Pamela S (2017) Controversies Regarding Use of Myeloid Growth Factors in Leukemia. J Natl Compr Canc Netw 15:1551-1557
Kamath-Loeb, Ashwini S; Zavala-van Rankin, Diego G; Flores-Morales, Jeny et al. (2017) Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep 7:44081

Showing the most recent 10 out of 137 publications